Group Opposes Caremark, Express Scripts Union

Law360, New York (January 30, 2007, 12:00 AM EST) -- A merger between pharmaceutical benefit top guns Caremark Rx Inc. and Express Scripts Inc. would further stifle an already concentrated market and make it even harder for smaller companies to break through, an antitrust think tank warned the Federal Trade Commission on Monday.

Based on its independent review, the American Antitrust Institute urged the FTC to consider six points, which reveal the problems that could emerge if Express Scripts takes over Caremark.

“The AAI believes that the proposed acquisition poses the threat of significant anti-competitive harm...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.